Fractional 1927nm Low-Powered Diode Laser combined with Topical Cysteamine for Melasma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
UnionDerm, New York, NYMelasmaFractional 1927nm Low-Powered Diode Laser - Device
Eligibility
18 - 74
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the effects of topical cysteamine cream with laser treatment in treating melasma. Participants will receive laser treatments and use topical cysteamine cream for 12 weeks.

Eligible Conditions
  • Melasma

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12 Weeks

12 Weeks
The primary objective of our study is to determine the efficacy of combined topical cysteamine cream with a 1927 diode non-ablative laser (Clear + Brilliant Permea®; Solta Medical, Inc.), compared to topical cysteamine alone in the treatment of melasma.

Trial Safety

Trial Design

2 Treatment Groups

Fractional 1927nm Low-Powered Diode Laser combined with Topical Cysteamine
1 of 2
Topical Cysteamine Alone
1 of 2

Active Control

20 Total Participants · 2 Treatment Groups

Primary Treatment: Fractional 1927nm Low-Powered Diode Laser combined with Topical Cysteamine · No Placebo Group · N/A

Fractional 1927nm Low-Powered Diode Laser combined with Topical CysteamineActiveComparator Group · 2 Interventions: Fractional 1927nm Low-Powered Diode Laser, Topical Cysteamine · Intervention Types: Device, Other
Topical Cysteamine Alone
Other
ActiveComparator Group · 1 Intervention: Topical Cysteamine · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks

Who is running the clinical trial?

UnionDermLead Sponsor
Solta MedicalIndustry Sponsor
7 Previous Clinical Trials
189 Total Patients Enrolled
Skin of Color SocietyUNKNOWN
1 Previous Clinical Trials
11 Total Patients Enrolled
ScientisUNKNOWN

Eligibility Criteria

Age 18 - 74 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Women with skin of any color or tone are eligible to participate.

Frequently Asked Questions

Is there an age limit to eligibility for this medical trial?

"Individuals must be of legal age and no older than 74 years old to take part in the trial, as these parameters were set for inclusion criteria." - Anonymous Online Contributor

Unverified Answer

Is enrollment for this investigation still open?

"According to the data provided by clinicaltrials.gov, this medical experiment is currently seeking participants. The trial was originally published on October 28th 2022 and recently revised on December 15th 2022." - Anonymous Online Contributor

Unverified Answer

What is the upper bound of participants taking part in this research endeavor?

"Affirmative. Per the details on clinicaltrials.gov, this medical trial is presently looking for volunteers to take part in it - with its initial posting date being October 28th 2022 and most recent update taking place December 15th 2022. The research requires 20 patients from a single site." - Anonymous Online Contributor

Unverified Answer

Would I be eligible to join this clinical examination?

"This clinical trial is welcoming 20 volunteers aged 18 to 74 who have melasma. To be eligible for this study, individuals must possess a Skin Type I-VI and understand the Informed Consent form; moreover, they need to commit to all subsequent follow-ups required by the research team." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.